The company
Treace Medical Concepts, Inc.
TMCI · Nasdaq
TMCI stood above a rising 150-day average in 15 of the last 52 weekly readings, including each of the last 15 weeks. It is 11.2% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 15 in a row
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $2.9M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 147 (-12)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| John T. TreaceChief Executive Officer | bought | 11,000at $4.34 | 24 Aug 2026filed 24 Aug 2026 |
| John T. TreaceChief Executive Officer | bought | 5,000at $4.35 | 21 Aug 2026filed 24 Aug 2026 |
| John T. TreaceChief Executive Officer | bought | 39,944at $4.44 | 20 Aug 2026filed 24 Aug 2026 |
| John T. TreaceChief Executive Officer | bought | 22,887at $4.04 | 11 Jun 2026filed 11 Jun 2026 |
| John T. TreaceChief Executive Officer | bought | 9,891at $4.04 | 11 Jun 2026filed 12 Jun 2026 |
| John T. TreaceChief Executive Officer | bought | 29,430at $4.02 | 10 Jun 2026filed 11 Jun 2026 |
| John T. TreaceChief Executive Officer | bought | 14,715at $4.02 | 10 Jun 2026filed 12 Jun 2026 |
| John T. TreaceChief Executive Officer | bought | 50,000at $3.56 | 1 Jun 2026filed 1 Jun 2026 |
| John T. TreaceChief Executive Officer | bought | 61,202at $3.02 | 28 May 2026filed 28 May 2026 |
| John T. TreaceChief Executive Officer | bought | 49,810at $2.87 | 27 May 2026filed 28 May 2026 |
| John T. TreaceChief Executive Officer | bought | 4,508at $2.79 | 26 May 2026filed 28 May 2026 |
| John T. TreaceChief Executive Officer | bought | 61,750at $2.62 | 14 May 2026filed 14 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| SAMSARA BIOCAPITAL, LLCadded · filed 14 Aug 2026 | 10,369,159$7.9M | +1,869,159+22.0% |
| RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026 | 8,500,000$6.5M | 00.0% |
| AWM Investment Company, Inc.added · filed 14 Aug 2026 | 7,500,000$5.7M | +1,000,000+15.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 6,591,464$11.5M | +507,390+8.3% |
| ARMISTICE CAPITAL, LLCunchanged · filed 14 Aug 2026 | 6,364,000$25.3M | 00.0% |
| BANK OF AMERICA CORPadded · filed 14 Aug 2026 | 3,305,100$13.2M | +90,807+2.8% |
| GAGNON SECURITIES LLCreduced · filed 5 Aug 2026 | 3,029,543$12.1M | -2,172,343−41.8% |
| Longaeva Partners L.P.unchanged · filed 14 Aug 2026 | 2,329,459$1.8M | 00.0% |
| Polar Asset Management Partners Inc.new · filed 14 Aug 2026 | 2,318,542$1.8M | +2,318,542 |
| Siren, L.L.C.unchanged · filed 13 Aug 2026 | 2,000,000$1.5M | 00.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.